Repurposed ALS drug shows promise in mouse model of rare childhood genetic disorder


Cover picture for the articleRiluzole, a drug approved to treat amyotrophic lateral sclerosis (ALS), a disease affecting nerve cells controlling movement, could slow the gradual loss of a particular brain cell that occurs in Niemann-Pick disease type C1 (NPC1), a rare genetic disorder affecting children and adolescents, suggests a study in mice by scientists at...

Comments / 1

Comments / 0